The research focuses on establishing a system for detecting loss of consciousness, developing clinical prognostic and awakening-related brain function testing criteria.
A framework for the acquisition of neural features, feature selection and mechanism analysis of consciousness deficits in patients with acute and prolonged disorders of consciousness(DOC). Based on the multimodal data of three types of patients with DOC, the investigators established a comprehensive scientific collection of brain function features of acute and prolonged consciousness disorders; Revealed the key neural nodes and circuits of consciousness deficits, and elucidated the neural mechanisms of consciousness deficits in patients with prolonged consciousness disorders from EEG time-frequency-spatial features;
Study Type
OBSERVATIONAL
Enrollment
500
Routine clinical rehabilitation
Xuan Wu hospitial, capical medical university
Beijing, China
Change from Coma recovery scale-revised
CRS-R scale includes 6 dimensions such as audiovisual, arousal level, verbal response, motor and communication, scoring 0 to 23, the higher the score the better the neurological function, and each score reflects the presence or absence of the evaluated person and the strength of consciousness
Time frame: Within 24 hours of enrollment
Change from the p300 in electroencephalogram
Assessment the p300 in event related potential(ERP)
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Change from resting-state in electroencephalogram
Assessment the spectral power and coherence by in resting-state EEG
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Change from TEP in electroencephalogram
Assessment the TMS Evoked Potential(TEP)
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Change from PCI in electroencephalogram
Assessment the perturbational complexity index(PCI) in TMS-EEG
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Change from ROI in neuroimage techniques-PET
The distribution of 18F-FDG in the brain was analyzed according to the imaging situation, and the brain regions of interest (ROI) were outlined, and the uptake of 18F-deoxyglucose (FDG) in the patients was observed according to the brain ROI.
Time frame: Assessment within 24 hours before ,and 1 hour after TMS treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.